Abstract:Objective:To investigate the efficacy and safety of the cold-cycle microwave ablation in combination with TACE in treating primary hepatocarcinoma.Methods:Forty-five cases of primary hepatocarcinoma were chosen.They were treated with trans-hepatic arterial in fusion chemotherapy and embolism(TACE).Most chemotherapeutic regimens were two-agent combinations(EPI+CDDP,GEM+CDDP or 5-FU+CDDP),and embolism agents included superliquid lipiodol(dose was given based on the volume and blood supply of tumor and hepatic function,usually 5 to 15 ml) and gelatin sponge.Patients whose tumors were well lipiodol-deposited were treated with TACE once a month for two to three times,then their reciduary foci were further treated with cold-cycle microwave ablation(power was 50 to 60W,each locus should be treated for 20 to 30 minutes).For patients whose tumors were badly lipiodol-deposited because of poor blood supply,they received cold-cycle microwave ablation after the first TACE(with the same power and time as those aforementioned).When all treatments finished,alterations of embolism/melt degree of loci,clinical symptoms,AFP and liver/kidney functions and blood regular test were evaluated by weighted CT,MR or DSA(digital subtract angiography) tests.Follow-up time was 3 years after the last treatment.Results:Among 45 patients with primary hepatocarcinoma,34 cases had hypervascular tumors and underwent TACE treatment,including 0 of CR,70.6%(24 of 34) of PR,17.6%(6 of 34) of SD and 11.8%(4 of 34) of PD,which achieved a clinical beneficial rate of 88.2%.Up to 62 hypervascular and hypovascular loci remained after TACE treatment.Under cold-cycle microwave ablation therapy,complete necrosis of loci occurred in 48 cases(77.4%),incomplete necrosis of loci occurred in 5 cases(8.1%) and partial necrosis of loci occurred in 9 cases(14.5%).11 cases had AFP beyond 400μg/L prior to cold-cycle microwave ablation therapy,AFP of 7 cases dropped to normal level,AFP of 2 cases decreased significantly compared with that of pretreatment,2 cases showed no change in AFP.The 1-,2-and 3-year survival rates were 73.3%,62.2% and 37.8%,respectively.The main chemotherapy-associated side effects included nausea,vomiting and anorexia,aleucocytosis and thrombocytopenia were within grade Ⅱ to Ⅲ.Embolism and microwave ablation related effects were local pain(NRS 4 to 6) and fever(mild to moderate).Overall,the above adverse effects were fully relieved after sympotomatic treatment,without severe complications and surgery-related deaths.Conclusion:In the therapy of primary hepatocarcinoma,imaging-guided cold-cycle microwave ablation in combination with TACE showed merits of obvious curative effect,little trauma,high safety and easy operation,which made it an effective combined minimally-invasive treatment method in targeting primary hepatocarcinoma.

Use of microwave tissue coagulator in hepatocellular carcinoma resection: compared with Lin's hepatic clamp.

Microwave Surgery in the Treatment of Hepatocellular Carcinoma

Analysis of the Clinical Efficacy of Liver Resection Combined with Adjuvant Microwave Coagulation for Patients with Hepatocellular Carcinoma

Clinical Assessment of Sonographically Guided Microwave Coagulation Therapy in Patients with Liver Carcinoma

915-Mhz Microwave-Assisted Laparoscopic Hepatectomy: a New Technique for Liver Resection

A comparison between microwave ablation and surgical resection for small hepatocellular carcinoma

Investigation on the clinical application of microwave ablation in the treatment of liver cancer

Microwave ablation: a new type of internally cooled microwave antenna in the treatment of patients with primary liver cancer

Making liver transection even safer: a novel use of microwave technology

Comparison Of The Therapeutic Effects Of Microwave Ablation And Surgical Resection For Small Hepatocellular Carcinoma.

Effect of Severity of Liver Cirrhosis on Surgical Outcomes of Hepatocellular Carcinoma After Liver Resection and Microwave Coagulation

Laparoscopic Hepatectomy Versus Microwave Ablation for Multifocal 3-5Cm Hepatocellular Carcinoma: a Multi-center, Real-world Study

Laparoscopic-assisted microwave ablation in treatment of small hepatocellular carcinoma: safety and efficacy in comparison with laparoscopic hepatectomy

Comparison of microwave ablation and radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis

Laparoscopic Microwave Ablation of Hepatocellular Carcinoma at Liver Surface: Technique Effectiveness and Long-Term Outcomes.

Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score–matched study

Microwave ablation in combination with TACE for the treatment of primary hepatic carcinoma

Microwave ablation of hepatocellular carcinoma as first-line treatment: long term outcomes and prognostic factors in 221 patients

Efficacy of microwave ablation with parallel acupuncture guided by ultrasound in treating single hepatocellular carcinoma in high-risk areas: A retrospective analysis of 155 patients

Short-term efficacy of microwave ablation in the treatment of liver cancer and its effect on immune function

Clinical research on the cold-cycle microwave ablation in combination with TACE in the treatment of primary hepatocarcinoma